<div class="container">

<table style="width: 100%;"><tr>
<td>armd.wide</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>armd.wide Data (240 x 10)</h2>

<h3>Description</h3>

<p>Data from Age-Related Macular Degeneration (ARMD)
clinical trial
</p>


<h3>Format</h3>

<p>The <code>armd.wide</code> data frame has 240 rows and 10 columns. Data are
stored in wide format with each row corresponding to one subject.
</p>

<dl>
<dt>subject</dt>
<dd>
<p> a factor with 240 levels <code>1</code>, <code>2</code>, <code>3</code>, <code>4</code>, <code>5</code>, ..., <code>240</code></p>
</dd>
<dt>lesion</dt>
<dd>
<p> an integer vector with values 1, 2, 3, 4 </p>
</dd>
<dt>line0</dt>
<dd>
<p> an integer vector with values ranging from 5 to 17</p>
</dd>
<dt>visual0</dt>
<dd>
<p> an integer vector with values of visual acuity measured at baseline ranging from 20 to 85</p>
</dd>
<dt>visual4</dt>
<dd>
<p> an integer vector with values of visual acuity measured at 4 weeks ranging from 12 to 84</p>
</dd>
<dt>visual12</dt>
<dd>
<p> an integer vector with values of visual acuity measured at 12 weeks ranging from 3 to 85</p>
</dd>
<dt>visual24</dt>
<dd>
<p> an integer vector with values of visual acuity measured at 24 weeks ranging from 5 to 85</p>
</dd>
<dt>visual52</dt>
<dd>
<p> an integer vector with values of visual acuity measured at 52 weeks from 4 to 85 </p>
</dd>
<dt>treat.f</dt>
<dd>
<p> a factor with 2 levels <code>Placebo</code>, <code>Active</code></p>
</dd>
<dt>miss.pat</dt>
<dd>
<p> a factor with 9 levels <code>----</code>, <code>---X</code>, <code>--X-</code>, <code>--XX</code>, <code>-XX-</code>, ...,<code>XXXX</code></p>
</dd>
</dl>
<h3>Details</h3>

<p>The ARMD data arise from a randomized multi-center
clinical trial comparing an experimental treatment
(interferon-alpha) versus placebo for patients diagnosed
with ARMD.
</p>


<h3>Source</h3>

<p>Pharmacological Therapy for Macular Degeneration Study
Group (1997).  Interferon alpha-IIA is ineffective for
patients with choroidal neovascularization secondary to
age-related macular degeneration. Results of a
prospective randomized placebo-controlled clinical trial.
Archives of Ophthalmology, 115, 865-872.
</p>


<h3>See Also</h3>

<p><code>armd</code>, <code>armd0</code>
</p>


<h3>Examples</h3>

<pre><code class="language-R">summary(armd.wide)
</code></pre>


</div>